PARP Inhibitors: Targeting the Right Patients

被引:1
|
作者
Azvolinsky, Anna
机构
关键词
D O I
10.1093/jnci/djs514
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1851 / +
页数:2
相关论文
共 50 条
  • [41] BRCA Mutations and PARP Inhibitors in Breast and/or Ovarian Cancer Patients
    Gari, Abdulrahim
    Rawas, Ghufran
    Mufti, Ahmad
    Elemam, Omima
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND ALLIED SCIENCES, 2021, 10 (03): : 33 - 49
  • [42] Hematological toxicities following treatment of cancer patients with PARP inhibitors
    Essam-Eldin, S.
    Salah, E.
    Ahmed, H.
    Elhalawani, H.
    Abdel-Rahman, O.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [43] The efficacy of PARP inhibitors in the treatment of patients with synchronous breast cancer
    Izrailbekova, Kamila
    Kamishov, Sergey
    Saydullaev, Sunnatilla
    Niyozova, Shakhnoza Khamoydinovna
    Tillyashaykhov, Mirzagaleb
    Olimjonova, Gulnoza
    Sobitov, Abdurakhmon
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [44] Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
    Murai, Junko
    Huang, Shar-yin N.
    Das, Benu Brata
    Renaud, Amelie
    Zhang, Yiping
    Doroshow, James H.
    Ji, Jiuping
    Takeda, Shunichi
    Pommier, Yves
    [J]. CANCER RESEARCH, 2012, 72 (21) : 5588 - 5599
  • [45] 7Synthetic lethal targeting of oncogenic transcription factors in acute leukemia by PARP inhibitors
    Esposito, Maria Teresa
    Zhao, Lu
    Fung, Tsz Kan
    Rane, Jayant K.
    Wilson, Amanda
    Martin, Nadine
    Gil, Jesus
    Leung, Anskar Y.
    Ashworth, Alan
    So, Chi Wai Eric
    [J]. NATURE MEDICINE, 2015, 21 (12) : 1481 - +
  • [46] Targeting glutaminase 1 to sensitize platinum-resistant BRCAwt ovarian cancer to PARP inhibitors
    Arend, R. C.
    [J]. GYNECOLOGIC ONCOLOGY, 2020, 159 : 138 - 138
  • [47] Design, synthesis and antitumor activity study of PARP-1/HDAC dual targeting inhibitors
    Chi, Ziwei
    Bai, Ying
    Li, Jing
    Wang, Kewei
    Xu, Yungen
    Luan, Yepeng
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 71
  • [48] Exploiting DNA damage repair defects for effective targeting of acute myeloid leukaemia by PARP inhibitors
    Esposito, M. T.
    Zhao, L.
    Fung, T. K.
    Rane, J.
    Wilson, A.
    Martin, N.
    Gil, J.
    Leung, A. Y.
    Ashworth, A.
    So, C. W. E.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 61 : S24 - S24
  • [49] PARP Inhibitors Sensitivity and Resistance
    Helleday, T.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S58 - S58
  • [50] Expanding the horizons of PARP inhibitors
    Teresa Villanueva
    [J]. Nature Reviews Drug Discovery, 2010, 9 : 919 - 919